INHIBACE 5 MG TBL FLM 28
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 263,12 Kč. Maximální cena: 328,62 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Monohydrát cilazaprilu (5,22 mg), cilazapril (5 mg), monohydrát laktosy, kukuřičný škrob, hypromelosa 2910/3, ointmentek, natrium-stearyl-fumarát, hypromelosa 2910/6, oxid titaničitý, červený oxid železitý. Další informace… |
| Dostupnost / výpadek | The latest report from the manufacturer is from 31. 1. 2020. Výroba je oficiálně zahájena od 29. 11. 2019. |
| Kód SÚKL | 0241413 |
What is the maximum co-payment for INHIBACE?
If the insurance company contributes, the maximum co-payment is 263,12 Kč. The maximum pharmacy price is 328,62 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does INHIBACE have a counted co-payment set?
Yes, the medicine has a counted co-payment of 173,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
65,50 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe INHIBACE?
Prescription is not conditional on a medical specialization.
What is the composition of INHIBACE?
Monohydrát cilazaprilu (5,22 mg), cilazapril (5 mg), monohydrát laktosy, kukuřičný škrob, hypromelosa 2910/3, ointmentek, natrium-stearyl-fumarát, hypromelosa 2910/6, oxid titaničitý, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to INHIBACE?
The medicine belongs to ATC group C09AA08 – Cilazapril. Medicines with the same active substance can be found here.
Who manufactures INHIBACE?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 31. 1. 2020. Production has been officially started as of 29. 11. 2019.
What is the unique code for INHIBACE?
The medicine has code 0241413. Code details can be found here.
How many packs of INHIBACE were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of INHIBACE were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026